{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:06:54Z","timestamp":1779340014944,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.humimm.2026.111711","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:00:33Z","timestamp":1773367233000},"page":"111711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the reliability of the PAK-LX HLA Class I bead in platelet transfusion compatibility testing"],"prefix":"10.1016","volume":"87","author":[{"given":"Haley","family":"Enten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhamid","family":"Liacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Janes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Stedem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Gaule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureddine","family":"Berka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111711_b0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1182\/hematology.2020000137","article-title":"Platelet transfusion refractoriness: how do I diagnose and manage?","volume":"1","author":"Cohn","year":"2020","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.humimm.2026.111711_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125367","article-title":"Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: from mechanisms and determinants to therapeutic prospects","volume":"14","author":"Couvidou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111711_b0015","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2306983","article-title":"Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics","volume":"35","author":"Chen","year":"2024","journal-title":"Platelets"},{"issue":"22","key":"10.1016\/j.humimm.2026.111711_b0020","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood.V114.22.4187.4187","article-title":"PAK\u2122-Lx: a New Luminex\u00ae-based Assay to Detect and Identify Antibodies to Human Platelet Antigens (HPA) in Patient Serum","volume":"114","author":"Rathore","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111711_b0025","doi-asserted-by":"crossref","DOI":"10.1111\/vox.13538","article-title":"An optimized procedure for Luminex-based human platelet antigen-specific antibody screening and identification (PakLx assay)","author":"Bertrand","year":"2023","journal-title":"Vox Sang."},{"issue":"Supplement","key":"10.1016\/j.humimm.2026.111711_b0030","article-title":"Comparative analysis of PAK LX and SAG in HLA class I antibody screening: Implications for transfusion medicine","volume":"85","author":"Gaule","year":"2024","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2026.111711_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101135","article-title":"Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management","volume":"62","author":"Panch","year":"2023","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.humimm.2026.111711_b0045","first-page":"250","article-title":"Management of HLA-mediated platelet transfusion refractoriness: recent literature review","volume":"34","author":"Pavenski","year":"2020","journal-title":"Transfusion Med Rev."},{"key":"10.1016\/j.humimm.2026.111711_b0055","doi-asserted-by":"crossref","unstructured":"Cabral LJB, Lopes DP, Filho EDSM, Valois RC, Oliveira PCAJ, Mendon\u00e7a-Mattos PJS. Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis. Hematol Transfus Cell Ther. 2025 Apr-Jun;47(2):103821. doi: 10.1016\/j.htct.2025.103821.","DOI":"10.1016\/j.htct.2025.103821"},{"issue":"5","key":"10.1016\/j.humimm.2026.111711_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.110857","article-title":"Direct addition of EDTA to LABScreen single antigen bead suspension: a simple way to prevent complement mediated interference and streamline HLA antibody testing","volume":"85","author":"Al Aufi","year":"2024","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111711_b0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2020.09.010","article-title":"Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness","volume":"34","author":"Saris","year":"2020","journal-title":"Transfus. Med. Rev."},{"issue":"6","key":"10.1016\/j.humimm.2026.111711_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15586","article-title":"Sensitive HLA antibody testing and the risk of antibody-mediated rejection and graft failure","volume":"103","author":"Debyser","year":"2024","journal-title":"HLA"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:14:26Z","timestamp":1779336866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0198885926000571"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111711","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the reliability of the PAK-LX HLA Class I bead in platelet transfusion compatibility testing","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111711"}}